• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Thursday, November 19, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

Acquired Angioedema Series Finds Universal Link to Underlying Hematologic Disorders

by
November 15, 2026
in Health
Reading Time: 3 mins read
0
Acquired Angioedema Series Finds Universal Link to Underlying Hematologic Disorders

Acquired Angioedema Series Finds Universal Link to Underlying Hematologic Disorders

Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

A province-wide retrospective study conducted across four allergy and immunology clinics in British Columbia has documented a consistent association between acquired angioedema and underlying hematologic disorders. Across the entire cohort, every patient was confirmed to have an underlying hematologic condition. Notably, for five of the eight individuals, the emergence of recurrent swelling episodes and the subsequent medical workup for acquired angioedema served as the initial clinical event that prompted formal hematologic evaluation.

Acquired angioedema represents an uncommon clinical condition marked by recurrent episodes of bradykinin-mediated soft tissue edema. Medical understanding indicates that this pathology develops secondary to dysfunction of the C1-esterase inhibitor regulatory protein, occurring most frequently in direct association with a coexisting hematologic disorder.

To ensure precise case identification, the investigators applied standardized inclusion criteria across the participating clinical sites. Patients were enrolled only if they had received a formal clinical diagnosis of acquired angioedema, had no documented family history suggestive of hereditary angioedema, and exhibited a biochemical profile consistent with acquired disease. Specifically, laboratory confirmation required evidence of low functional activity of the C1-esterase inhibitor regulatory protein alongside low serum levels of complement component C4. Through retrospective medical record reviews, the authors systematically gathered information regarding each patient’s epidemiologic profile, potential inciting triggers, initial presenting symptoms, the frequency and severity of swelling attacks, and recorded responses to both acute interventions and long-term prophylactic therapies.

The demographic and diagnostic data showed that the median age of patients at the time of presentation or formal diagnosis was 59 years. In examining the anatomical distribution of swelling episodes, the study identified distinct patterns of involvement across the cohort. All eight patients experienced abdominal swells as part of their initial presenting symptoms. In addition to widespread gastrointestinal involvement, six of the eight patients experienced swelling in the facial, oropharyngeal, or upper airway regions.

The case series tracked the efficacy of acute therapeutic interventions administered to control active swelling episodes. Five of the eight patients received acute treatment with intravenous C1-esterase inhibitor replacement therapy, with four of those five individuals demonstrating documented clinical improvement. Furthermore, three patients received the acute targeted agent icatibant during attack episodes. All three individuals treated with icatibant experienced significant clinical improvement or complete resolution of their angioedema symptoms.

Patient responses to chronic prophylactic regimens were characterized as more heterogeneous across the cohort. Nevertheless, definitive management of the associated hematologic disease produced clear secondary benefits for angioedema control. Specifically, patients who received curative medical treatment targeting their underlying hematologic malignancy uniformly achieved complete or near-complete remission of their angioedema symptoms. Targeted maintenance therapies also proved effective in individual cases; one patient diagnosed with chronic lymphocytic leukemia achieved complete remission of acquired angioedema symptoms following preventative administration of lanadelumab. The clinical records further suggested that historical therapeutic options such as danazol and regular C1-esterase inhibitor replacement continue to show meaningful treatment effects, while newer agents such as icatibant and lanadelumab demonstrate excellent clinical responsiveness.

Given that abdominal swelling occurred in every patient in the cohort, the researchers proposed that acquired angioedema should be actively considered in the differential diagnosis when patients with suspected hematologic disorders develop new abdominal symptoms of unclear etiology.

Subject of Research: Clinical characteristics and hematologic associations of acquired angioedema

Article Title: Acquired angioedema in British Columbia: a province-wide collaborative case series

Article References: Cahill, J. A., Bansal, A., Jagdis, A., Kanani, A., Reeves, H., Weir, N., & Kan, M. (2026). Acquired angioedema in British Columbia: a province-wide collaborative case series. Allergy, Asthma & Clinical Immunology. https://doi.org/10.1186/s13223-026-01082-6

Image Credits: AI Generated

DOI: 10.1186/s13223-026-01082-6

Keywords: Acquired angioedema, C1-esterase inhibitor, Hematologic disorders, Bradykinin-mediated edema, Abdominal swelling, Upper airway swelling, Icatibant, Lanadelumab, Danazol, Chronic lymphocytic leukemia, Complement component C4, British Columbia, Case series, Allergy and immunology, Intravenous C1-INH replacement, Soft tissue edema, Hereditary angioedema

News Source: Ophelia Keating. (November 15, 2026). Acquired Angioedema Series Finds Universal Link to Underlying Hematologic Disorders. Scienmag.

Tags: Abdominal swellingacquired angioedemaallergy and immunologyBradykinin-mediated edemaBritish ColumbiaC1 esterase inhibitorcase serieschronic lymphocytic leukemiaComplement component C4danazolHematologic disordershereditary angioedemaIcatibantIntravenous C1-INH replacementlanadelumabSoft tissue edemaUpper airway swelling
Share12Tweet7Share2ShareShareShare1

Related Posts

Elevated TCBI and HbA1c Jointly Predict Incident Diabetes in Older Chinese Adults

Elevated TCBI and HbA1c Jointly Predict Incident Diabetes in Older Chinese Adults

November 19, 2026
Composite Metabolic Adiposity Indices Predict Incident Diabetes in Adults With Clinical Obesity

Composite Metabolic Adiposity Indices Predict Incident Diabetes in Adults With Clinical Obesity

November 19, 2026

Study Finds ChatGPT Outperforms Gemini and Copilot on Basic Orthodontic Questions

November 19, 2026

Faricimab Resolves Refractory Macular Edema in Two UGH Syndrome Cases

November 19, 2026

POPULAR NEWS

  • Anlotinib Combined with Cranial Radiotherapy Shows Promise for Lung Cancer Brain Metastases

    Anlotinib Combined with Cranial Radiotherapy Shows Promise for Lung Cancer Brain Metastases

    29 shares
    Share 12 Tweet 7
  • Curcumin Reduces Liver Steatosis in Rats by Altering Gut Microbiota and Epigenetics

    29 shares
    Share 12 Tweet 7
  • Air Sampling in Bat Caves Captures Mammalian Viruses Across Optimized Volumes

    29 shares
    Share 12 Tweet 7
  • Rimegepant Provides Meaningful Relief as Second- or Third-Line Acute Migraine Therapy

    29 shares
    Share 12 Tweet 7

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Elevated TCBI and HbA1c Jointly Predict Incident Diabetes in Older Chinese Adults

Dual-Branch Computer Vision Framework Boosts Underwater Marine Debris Detection Accuracy

Composite Metabolic Adiposity Indices Predict Incident Diabetes in Adults With Clinical Obesity

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 89 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.